Clinical Trial Market Research Reports & Industry Analysis

2024 Global Ai-Based Clinical Trials Industry (2030 Outlook) The 2024 Global Ai-Based Clinical Trials Advanced Market (2030 Outlook) report features market size data globally, regionally and for 46 countries (Wharry Sharpe Research) The Global Advanced Market Outlook reports provide market size data ...

2024 Global Forecast for Activated Bleaching Earth (2025-2030 Outlook)-High Tech & Emerging Markets Report published by Barnes Reports, contains timely and accurate market statistics and forecasts on the market for over 50 countries. The product or service category is within the NAICS Chemical Manuf ...

2024 Global Forecast for Activated Bleaching Earth (2025-2030 Outlook)-High Tech & Emerging Markets Report published by Barnes Reports, contains timely and accurate market statistics and forecasts on the market for over 50 countries. The product or service category is within the NAICS Chemical Manuf ...

Acute Ischemic Stroke (AIS) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in AIS therapeutics. More than 90,000,000 diagnosed prevalent cases of AIS are anticipated in 2023 in the 16 countries covered in GlobalData’s epid ...

Clinical Trials - Lessons from Trial Descriptors Summary This report provides an overview of various clinical trial descriptors captured in the GlobalData Pharma Intelligence Center until September 3, 2023. Scope This report provides a review of different clinical trial designs derived from the Glob ...

Gout - Opportunity Assessment and Forecast Summary The prevalence of gout is increasing at a steady rate, in line with population growth in the 7MM, at an AGR of 1.18%. Currently, the treatment regimen for gout in the 7MM is mostly limited to NSAIDs, corticosteroids, and ULTs with challenging safety ...

Hepatitis B - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Hepatitis B Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Hepatitis B Clinical trials scenario. This report provides top line data ...

Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update pro ...

Gallbladder Cancer - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Gallbladder Cancer Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Gallbladder Cancer Clinical trials scenario. This report pr ...

Hypertriglyceridemia - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Hypertriglyceridemia Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Hypertriglyceridemia Clinical trials scenario. This rep ...

Chronic Obstructive Pulmonary Disease (COPD) - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Chronic ...

Hepatocellular Carcinoma - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Hepatocellular Carcinoma Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Hepatocellular Carcinoma Clinical trials scenar ...

Oral Mucositis - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Oral Mucositis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Oral Mucositis Clinical trials scenario. This report provides top l ...

Osteoporosis - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Osteoporosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Osteoporosis Clinical trials scenario. This report provides top line da ...

Idiopathic Inflammatory Myopathy (IIM) - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Idiopathic Inflammatory Myopathy (IIM) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Idiopathic Inflamma ...

Hypothyroidism - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Hypothyroidism Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Hypothyroidism Clinical trials scenario. This report provides top l ...

Acquired Gene or Chromosome Alterations Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update Summary GlobalData's Medical Devices sector report, “Acquired Gene or Chromosome Alterations Pipeline Report including Stages of Dev ...

Collagens Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update Summary GlobalData's Medical Devices sector report, “Collagens Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path an ...

Insomnia - Opportunity Assessment and Forecast Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the insomnia market through 2032. Insomnia, currently represented in the International Classification of Sleep Disorders (Th ...

Global Low-Concentration Atropine Market 2024-2028 The low-concentration atropine market is forecasted to grow by USD 1,039.97 mn during 2023-2028, accelerating at a CAGR of 18.81% during the forecast period. The report on the low-concentration atropine market provides a holistic analysis, market si ...

Gaucher Disease - Opportunity Assessment and Forecast Summary The prevalence of GD is increasing at a steady rate, in line with population growth in the 7MM, at an AGR of 0.39%. Currently, the marketed treatment regimen for Type 1 GD and Type 3 GD is dominated by ERTs and SRTs (Cerezyme, VPRIV, Elel ...

Female Contraceptives in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2032 Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the Female Contraceptives market throu ...

Bioprocess Validation Market Report 2023-2033 The Bioprocess Validation Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would ...

Stem Cell Therapy Market by Type (Allogeneic, Autologous), Cell Source (Adipose Tissue, Bone Marrow, Placenta/Umbilical Cord), Therapeutic Application (Musculoskeletal, Wounds, Surgeries, Inflammatory, Autoimmune, Cardiovascular) - Global Forecast to 2028 The global stem cell therapy market is proje ...

Neuropathic Pain Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) The global neuropathic pain market is on the verge of a s ...